Evaluate the Effectiveness of the Mobile Instant Messaging Intervention

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-80
SponsorNational Taipei University of Nursing and Health Sciences

About this trial

This study explores the caregiving needs of male spouses and develops an instant messaging software intervention to provide effective support. The goal is to help male spouses better adjust to their caregiving roles, reduce psychological stress and emotional distress, and improve overall health.

A randomized controlled trial will be conducted to evaluate the effectiveness of the mobile instant messaging intervention, analyzing its impact on reducing psychological distress and improving the quality of life of male spouses.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age 18 or older, with a diagnosis of gynecological cancer (including cancers of the cervix, endometrium, fallopian tubes, ovaries, uterus, or vagina), and whose spouse has not been diagnosed with any other type of cancer;

The spouse has undergone cancer treatment, including surgery, chemotherapy, or radiotherapy;

Clear consciousness and ability to communicate in Mandarin or Taiwanese;

Willingness to participate in the study after being informed of the study purpose and procedures.

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • instant messaging software

    Behavioral

    instant messaging software

Treatment groups

70 Participants
are divided into 2 treatment groups
Group A: instant messaging softwareExperimental treatment 1 intervention
Group B: "Control Group"No intervention 0 interventions

Trial outcomes

Primary outcomes

1

Supportive Care Needs -Partners & Caregivers 45, SCNS-P&C45

Time frame
Post-intervention assessments will be conducted at 1 month, 3 months, and 6 months after the intervention.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: